Healthcare Co.,Ltd. (SHA:603313)
China
· Delayed Price · Currency is CNY 8.20
-0.09 (-1.09%)
Jun 19, 2025, 2:45 PM CST
Healthcare Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 8,456 | 8,232 | 7,759 | 7,786 | 7,912 | 6,354 | Upgrade
|
| Other Revenue | 217.37 | 217.37 | 217.21 | 231.56 | 227.36 | 176.02 | Upgrade
|
| Revenue | 8,673 | 8,449 | 7,976 | 8,017 | 8,139 | 6,530 | Upgrade
|
| Revenue Growth (YoY) | 7.13% | 5.94% | -0.52% | -1.50% | 24.64% | 70.43% | Upgrade
|
| Cost of Revenue | 5,478 | 5,357 | 4,948 | 5,547 | 5,876 | 4,349 | Upgrade
|
| Gross Profit | 3,196 | 3,092 | 3,028 | 2,471 | 2,263 | 2,181 | Upgrade
|
| Selling, General & Admin | 2,590 | 2,526 | 2,300 | 2,032 | 1,947 | 1,309 | Upgrade
|
| Research & Development | 150.82 | 141.51 | 115.66 | 95.31 | 124.25 | 110.16 | Upgrade
|
| Other Operating Expenses | 43.91 | 42.42 | 47.41 | 46.53 | 30.38 | 25.63 | Upgrade
|
| Operating Expenses | 3,158 | 3,084 | 2,545 | 2,213 | 2,157 | 1,480 | Upgrade
|
| Operating Income | 37.35 | 7.91 | 482.9 | 257.36 | 106.66 | 701.68 | Upgrade
|
| Interest Expense | -170.38 | -181.99 | -214.03 | -182.32 | -140.52 | -80.26 | Upgrade
|
| Interest & Investment Income | 10.99 | 11.75 | 3.63 | 50.88 | 21.29 | 19.65 | Upgrade
|
| Currency Exchange Gain (Loss) | 23.92 | 23.92 | 33.61 | 120.64 | -72.14 | -105.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -27.56 | -14.34 | -139.43 | -124.37 | -149.75 | -81.68 | Upgrade
|
| EBT Excluding Unusual Items | -125.67 | -152.75 | 166.68 | 122.2 | -234.45 | 454.13 | Upgrade
|
| Impairment of Goodwill | -37.57 | -37.57 | -9.53 | -2.24 | -0.46 | -0.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.88 | -7.93 | -12.5 | -29 | 4.52 | 25.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 14.95 | 15.74 | -0.04 | -2.88 | -4.8 | -0.69 | Upgrade
|
| Asset Writedown | 2.16 | - | -4.23 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | -108.26 | - | Upgrade
|
| Other Unusual Items | 17.1 | 17.52 | 24.02 | -6.71 | 69.13 | -4.46 | Upgrade
|
| Pretax Income | -125.41 | -164.25 | 164.47 | 81.37 | -274.16 | 474.59 | Upgrade
|
| Income Tax Expense | 22.13 | 14.71 | 42.93 | 29.4 | -4.53 | 57.94 | Upgrade
|
| Earnings From Continuing Operations | -147.55 | -178.96 | 121.54 | 51.97 | -269.64 | 416.65 | Upgrade
|
| Minority Interest in Earnings | 35.02 | 27.54 | -14.94 | -10.61 | -5.89 | -38.07 | Upgrade
|
| Net Income | -112.52 | -151.42 | 106.6 | 41.36 | -275.53 | 378.59 | Upgrade
|
| Net Income to Common | -112.52 | -151.42 | 106.6 | 41.36 | -275.53 | 378.59 | Upgrade
|
| Net Income Growth | - | - | 157.74% | - | - | 1.31% | Upgrade
|
| Shares Outstanding (Basic) | 542 | 561 | 485 | 460 | 483 | 443 | Upgrade
|
| Shares Outstanding (Diluted) | 542 | 561 | 485 | 460 | 483 | 447 | Upgrade
|
| Shares Change (YoY) | 6.37% | 15.74% | 5.44% | -4.93% | 8.04% | 4.07% | Upgrade
|
| EPS (Basic) | -0.21 | -0.27 | 0.22 | 0.09 | -0.57 | 0.85 | Upgrade
|
| EPS (Diluted) | -0.21 | -0.27 | 0.22 | 0.09 | -0.57 | 0.85 | Upgrade
|
| EPS Growth | - | - | 144.44% | - | - | -2.65% | Upgrade
|
| Free Cash Flow | 594.72 | 584.57 | 502.1 | -65.68 | -471.52 | -332.91 | Upgrade
|
| Free Cash Flow Per Share | 1.10 | 1.04 | 1.04 | -0.14 | -0.97 | -0.74 | Upgrade
|
| Dividend Per Share | 0.050 | 0.050 | - | - | - | 0.269 | Upgrade
|
| Gross Margin | 36.85% | 36.60% | 37.96% | 30.82% | 27.81% | 33.40% | Upgrade
|
| Operating Margin | 0.43% | 0.09% | 6.05% | 3.21% | 1.31% | 10.75% | Upgrade
|
| Profit Margin | -1.30% | -1.79% | 1.34% | 0.52% | -3.38% | 5.80% | Upgrade
|
| Free Cash Flow Margin | 6.86% | 6.92% | 6.30% | -0.82% | -5.79% | -5.10% | Upgrade
|
| EBITDA | 588.47 | 549.94 | 988.58 | 493.78 | 295.53 | 834.65 | Upgrade
|
| EBITDA Margin | 6.78% | 6.51% | 12.39% | 6.16% | 3.63% | 12.78% | Upgrade
|
| D&A For EBITDA | 551.12 | 542.03 | 505.67 | 236.42 | 188.86 | 132.97 | Upgrade
|
| EBIT | 37.35 | 7.91 | 482.9 | 257.36 | 106.66 | 701.68 | Upgrade
|
| EBIT Margin | 0.43% | 0.09% | 6.05% | 3.21% | 1.31% | 10.75% | Upgrade
|
| Effective Tax Rate | - | - | 26.10% | 36.13% | - | 12.21% | Upgrade
|
| Revenue as Reported | 8,673 | 8,449 | 7,976 | 8,017 | 8,139 | 6,530 | Upgrade
|
| Advertising Expenses | - | 281.14 | 227.4 | 190.11 | 196.31 | 143.59 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.